Sustainability

Research Group Prof. Dr. Zoya Ignatova

SDG 03: Good health and well-beeing

The Ignatova group conducts cutting-edge research at the intersection of molecular biology, biochemistry, and molecular medicine, with a particular focus on the role of translational control and protein biogenesis in human health and disease. The work addresses the fundamental biological processes underlying a range of severe, currently incurable conditions, ranging from monogenic disorders, to complex genetic and non-genetic conditions. Along with elucidating fundamental mechanisms of translational control, the group is deeply engaged in unraveling molecular processes challenging translation and driving pathological states. The research provides valuable insights into the molecular states of diseases, guiding the development of innovative gene therapies to combat these pathologies.

This research directly supports Sustainable Development Goal 3 by fostering scientific progress in understanding fundamental molecular mechanisms to unravel the molecular foundation of various pathologies and drive innovative therapeutic interventions. These innovations hold great promise for the advancement of treatment options for currently intractable diseases, directly aligning with and supporting SDG 3 by reducing mortality and improving the quality of life for the affected individuals.

SDG 12: Responsible Consumption and Production

A central focus of the research group is to develop research solutions that consider sustainability goals. This includes improving the sensitivity of the methods to minimize the sample size and volume, which consequently reduces the use of chemicals and energy consumption in the analytical procedures. Beyond these measures, the group continuously engages in discussions about the responsible use of resources, such as chemicals and energy, intending to conduct sustainable research.